ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,953Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 886

$735K Total Retail Price of All Prescriptions

Rank: 16 out of 886

637 Patients Receiving at Least One Drug in Part D
34%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 637 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

42% of this provider’s 637 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 3,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 1,271 319 S3 1 1
SIMVASTATIN 413 192 2 3
GABAPENTIN 367 103 3 8
LISINOPRIL 364 93 4 2
OMEPRAZOLE 316 124 5 4
METFORMIN HCL 280 114 6 6
FUROSEMIDE 256 63 7 10
ZOLPIDEM TARTRATE 215 55 8 13
POTASSIUM CHLORIDE 187 52 9 17
RANITIDINE HCL 181 54 10 15
HYDROCHLOROTHIAZIDE 159 58 11 12
LEVOTHYROXINE SODIUM 156 40 12 5
PROMETHAZINE HCL 153 20 R 13 41
METOPROLOL TARTRATE 152 74 14 11
CYCLOBENZAPRINE HCL 148 15 R 15 37
MORPHINE SULFATE ER 132 17 S2 16 14
AZITHROMYCIN 128 31 17 29
MELOXICAM 126 41 18 18
AMLODIPINE BESYLATE 124 79 19 7
ENDOCET 115 31 S2 20 34
CRESTOR 115 32 20 36
NEXIUM 112 0 22 19
PROAIR HFA 111 25 23 20
CITALOPRAM HBR 108 23 24 16
WARFARIN SODIUM 98 56 25 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 32 26 26
ALENDRONATE SODIUM 97 60 26 60
ALLOPURINOL 94 29 28 56
FLUOXETINE HCL 90 27 29 50
IBUPROFEN 90 0 29 72
SERTRALINE HCL 88 48 31 35
OXYCODONE HCL 86 0 S2 32 9
CARISOPRODOL 86 0 R 32 28
LYRICA 84 0 34 48
DEXILANT 83 0 35 62
TRAMADOL HCL 83 24 35 24
AMITRIPTYLINE HCL 83 26 R 35 54
CLOPIDOGREL 82 37 38 44
ROPINIROLE HCL 82 0 38 110
PANTOPRAZOLE SODIUM 72 26 40 49
AMOXICILLIN 69 24 41 117
SPIRIVA 65 19 42 40
TRAZODONE HCL 65 0 42 39
PROPRANOLOL HCL 64 39 44 146
CIPROFLOXACIN HCL 63 29 45 67
CYMBALTA 63 0 45 52
PAROXETINE HCL 62 28 47 66
COMBIVENT 61 0 48 113
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 20 48 96
INSULIN SYRINGE 60 20 50 104
AMOX TR-POTASSIUM CLAVULANATE 60 14 50 101
OXYCONTIN 59 12 S2 52 33
GLIMEPIRIDE 57 18 53 47
ZETIA 52 0 54 122
BACLOFEN 52 0 54 55
LOVASTATIN 51 25 56 25
CARVEDILOL 51 21 56 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.